Screen shot. Only two events. Immutep is up for PDUFA alongside BMS’s Relatlimab. Provisional approval for Efti?
The phase2b was potentially a registrational trial of the highest standard. The blockbuster results in under 65’s and low monocytes would be too good to delay release, imo. There’s already enough trial evidence there are no side effects and the quality and length of life is significantly improved in a patient group with no options. It’s a lay down they will want to release Efti into MBC patients asap, imo, on a provisional basis.
Get in quick. we are going to the moon.
Ann: Phase II TACTI-002 trial recruitment successfully completed, page-31
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.015(4.92%) |
Mkt cap ! $464.8M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 32.5¢ | 30.0¢ | $1.168M | 3.702M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 148547 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 51809 | 2 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |